As companies eye opportunities to invest in and locate new business, technology, and cutting-edge R&D in China, the implementation of the Third Amendment to China’s patent law will have a significant impact on your business transactions and IP portfolio management.
This Foley Web conference in our Global Marketplace — Eye on China: Web Series, explored how companies can successfully implement and integrate IP and business strategies in light of the changes brought about by the Third Amendment.
Specific topics included:
- Promoting increased technology R&D in China — Does the Third Amendment aid or impede this trend?
- The import/export of technology to/from China through licensing or sale transactions: What new issues will arise in the wake of the Third Amendment?
- Protecting IP through nondisclosure agreements and noncompete provisions in labor law
- Will the Third Amendment stimulate further development of the manufacturing sector in China?
Moderator:
- Catherine Sun: Foley Shanghai Office Managing Partner and Asia Practice Chair
Speakers:
- Roger Martin: Qualcomm Senior Vice President and Chief IP Strategist
- Jon W. Dudas: Foley Partner and former Under Secretary of Commerce for Intellectual Property and Director of the USPTO
- Ken Duck: Foley Senior Counsel and member of the firm’s China and International practices and Automotive Industry Team
- Yan Zhao: Foley Senior Counsel and member of the firm’s International and Electronics practices and Automotive Industry Team
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.